Taipei, Taiwan

Jui-Hao Lee

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Everfront Biotech Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jui-Hao Lee. Retrieved from https://idiyas.com/inventor/jui-hao-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jui-Hao Lee and a Patent Application for Meningioma Treatment.

Introduction

Jui-Hao Lee is an inventor associated with Taipei, Taiwan, and Everfront Biotech Inc. His listed patent concerns the potential use of phthalide compounds in treating meningioma and reducing its recurrence.

Latest Patents

Lee is credited with 1 patent: “Use of Phthalide Compounds in Treatment of Meningioma.” The invention describes using compounds of formulas (I) and (II), or their pharmaceutically acceptable salts, to treat meningioma and reduce the likelihood of recurrence. The formulas specify possible substituents, including alkyl, cycloalkyl, aryl, alkoxy, aryloxy, and halogen groups, with defined ranges for their structures.

Career Highlights

Lee’s listed work connects his inventorship with Everfront Biotech Inc. The patent focuses on a therapeutic approach to meningioma, a type of tumor, and on addressing the risk of its return after treatment.

Collaborations

Lee’s listed coworker is Tsung-Lang Chiu. The available information identifies her as a coworker but does not specify her role in the patent or the research.

Conclusion

Jui-Hao Lee’s listed patent explores phthalide compounds as a potential approach to treating meningioma and reducing recurrence, reflecting his documented connection to biomedical innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…